GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » Earnings Yield (Joel Greenblatt) %

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Earnings Yield (Joel Greenblatt) % : 3.70% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings Yield (Joel Greenblatt) %?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value for the quarter that ended in Dec. 2023 was ₺14,659 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₺691 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was 3.70%.

The historical rank and industry rank for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

IST:GENIL' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.66   Med: 6.39   Max: 14.77
Current: 3.58

During the past 6 years, the highest Earnings Yield (Joel Greenblatt) of Gen Ilac Veglik Urunlerinayi ve Ticaret AS was 14.77%. The lowest was 2.66%. And the median was 6.39%.

IST:GENIL's Earnings Yield (Joel Greenblatt) % is ranked better than
56.87% of 1092 companies
in the Drug Manufacturers industry
Industry Median: 2.62 vs IST:GENIL: 3.58

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings Yield (Joel Greenblatt) % Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial - - 10.24 3.72 3.70

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.72 3.83 4.74 3.49 3.70

Competitive Comparison of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) % falls into.



Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Gen Ilac Veglik Urunlerinayi ve Ticaret ASs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=541.855/14658.967
=3.70 %

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺691 Mil.



Gen Ilac Veglik Urunlerinayi ve Ticaret AS  (IST:GENIL) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Traded in Other Exchanges
N/A
Address
Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines